Equities

ProMIS Neurosciences Inc

ProMIS Neurosciences Inc

Actions
  • Price (EUR)0.915
  • Today's Change-0.005 / -0.54%
  • Shares traded0.00
  • 1 Year change-27.38%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year ProMIS Neurosciences Inc had revenues remain flat at 0.00, though the company grew net income from a loss of 18.06m to a smaller loss of 13.21m.
Gross margin--
Net profit margin--
Operating margin--
Return on assets-839.15%
Return on equity--
Return on investment--
More ▼

Cash flow in USDView more

In 2023, ProMIS Neurosciences Inc increased its cash reserves by 114.41%, or 6.72m. Cash Flow from Financing totalled 17.75m or -- of revenues. In addition the company used 10.84m for operations while cash used for investing totalled 1.35k.
Cash flow per share-0.6838
Price/Cash flow per share--
Book value per share-0.1201
Tangible book value per share-0.1201
More ▼

Balance sheet in USDView more

ProMIS Neurosciences Inc appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio0.4444
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.